Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Goodwill & Intangibles: 2009-2024

Historic Goodwill & Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $18.9 million.

  • Cumberland Pharmaceuticals' Goodwill & Intangibles fell 21.67% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 21.67%. This contributed to the annual value of $18.9 million for FY2024, which is 19.70% down from last year.
  • Cumberland Pharmaceuticals' Goodwill & Intangibles amounted to $18.9 million in FY2024, which was down 19.70% from $23.5 million recorded in FY2023.
  • Cumberland Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $31.5 million for FY2022, and its period low was $18.9 million during FY2024.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $23.5 million (2023), whereas its average is $24.6 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first increased by 26.85% in 2022, then fell by 25.34% in 2023.
  • Cumberland Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $29.0 million in 2020, then fell by 14.36% to $24.8 million in 2021, then grew by 26.85% to $31.5 million in 2022, then declined by 25.34% to $23.5 million in 2023, then dropped by 19.70% to $18.9 million in 2024.